Prognostic Factors in Patients Dying of Well-Differentiated Thyroid Cancer
- 1 March 1989
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 115 (3), 326-330
- https://doi.org/10.1001/archotol.1989.01860270068017
Abstract
• While some well-differentiated cancers of the thyroid gland are unusually aggressive, most have a more benign clinical behavior, making it difficult to evaluate factors possibly influencing patient survival such as initial surgical treatment. By studying 135 patients who received their initial surgical therapy at our institution, we have defined the prognostically significant factors. Sixteen patients (11.9%) died of disease during a ten- to 20-year follow-up period. Significant factors associated with death from disease were aged 40 years or older, primary lesion size of 2.5 cm or greater, presence of invasive characteristics, and presence of distant metastases. We recommend total thyroidectomy and postoperative sodium iodide I 131 therapy in patients 40 years of age or older, while suggesting a less aggressive approach may be appropriate in the younger patients. (Arch Otolaryngol Head Neck Surg 1989;115:326-330)This publication has 4 references indexed in Scilit:
- Thyroid Cancer in Children and TeenagersJAMA Otolaryngology–Head & Neck Surgery, 1984
- The Treatment of Differentiated Carcinoma of the Thyroid Gland: Selective Management?JAMA Otolaryngology–Head & Neck Surgery, 1983
- A computer program for comparing K samples with right-censored dataComputer Programs in Biomedicine, 1972
- Total Thyroidectomy for Cancer of the Thyroid: Significance of Intraglandular DisseminationAnnals of Surgery, 1959